Neuroform atlas
The Neuroform Atlas is a self-expanding, microcatheter-delivered stent used for the treatment of wide-necked, intracranial aneurysms. It is designed to provide a scaffold to assist in the coiling of the aneurysm.
9 protocols using neuroform atlas
Endovascular Approach for Basilar Artery Occlusion
Stent-Assisted Coiling for Unsecured Aneurysms
Intracranial Aneurysm Stent-Assisted Coiling
Comprehensive Stroke Care Cost Analysis
Hospital costs for acute stroke care as well as post-hospitalization costs within the first 365 days were included from a nation-wide cost analysis of acute stroke care costs by Mu et al. (16 (link)) Costs for EVT as well as long-term healthcare costs of stroke survivors were estimated according to a previous long-term projection of a patient cohort of n = 428 (12 (link)). Acute care costs of recurrent strokes were estimated based on Chambers et al. (17 (link)) Costs of additional stent placement was estimated, based on costs of the Neuroform Atlas® Stent (Stryker, United States). For sensitivity analysis, all costs were modulated using γ-distributions.
Cell-through Single-Catheter Stent-Assisted Coiling
All the 16 cases underwent digital subtraction angiography (DSA) and rotational angiography (Philips Allura FD20 Clarity System, Philips Medical Systems, Best, The Netherlands) with three-dimensional reconstructions to characterize aneurysm and parent artery anatomy (Allura 3D-RA workstation, Philips Medical Systems). From these DSA results, proximal parent arteries, including the extracranial ICA or VA, were determined to use a smaller (< 6-Fr) guiding catheter due to its small-caliber, stenosis, or tortuous course. Wide-necked aneurysms were defined as having a neck width ≥ 4 mm or a dome-to-neck ratio of < 2 [2 (link), 3 (link)].
Retrospective Analysis of SACE Outcomes
Evaluating Cerebral Aneurysm Treatment Outcomes
women. Patient age ranged from 56–77 years with a mean of 68.8 years. All the
patients underwent 3D-TOF MRA and VWI in one magnetic resonance (MR) examination
session after undergoing stent-assisted treatment between January 2018–May 2019.
The interval between DSA and MR imaging was a minimum of 1 day, a maximum of 10
days, and an average of 2.8 days. Ten patients underwent stent-assisted coil
embolization for a cerebral aneurysm. The locations of the cerebral aneurysms
were as follows: intracranial artery (ICA), 5; middle cerebral artery (MCA), 1;
anterior communicating artery (A-com), 1; vertebral artery (VA), 2; and basilar
artery (BA), 1. The remaining patient underwent PTA and stenting for symptomatic
MCA stenosis. The stents used for the treatments were as follows: Neuroform
Atlas (Stryker Neurovascular Fremont, California, USA), 4; LVIS (MicroVention,
California, USA), 5; LVIS Jr (MicroVention, California, USA), 1; and Enterprise
(Codman and Shurtleff, Miami, USA), 1. This study is a retrospective study using
MR images that were obtained in routine examinations, and there is no
information included in the submitted material that allows identification of the
patients. So, informed consent was not obtained. All research activities were
performed in accordance with the Declaration of Helsinki.
Microcatheter Tip Modification for Stent-Assisted Coiling
Retrospective Analysis of NeuroForm Atlas Stent-Assisted Coil Embolization
In addition to aneurysm-related information (location, size, prior treatment, and dome-neck ratio), we collected detailed procedural information regarding the techniques used (i.e., jailing or trans-strut technique), angiographic outcomes (Raymond-Roy occlusion classification, RROC), and periprocedural complications. Follow-up clinical and angiographic data were also obtained. In-stent stenosis was defined as narrowing of the vessel by more than 10%. Angiographic results were independently adjudicated by two neurovascular specialists.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!